American International Group, Inc. (NYSE:AIG ) Q4 2024 Earnings Conference Call February 12, 2025 8:30 AM ET Company Participants Quentin McMillan - Investor Relations Peter Zaffino - Chairman and Chief Executive Officer Keith Walsh - Executive Vice President and Chief Financial Officer Jon Hancock - Executive Vice President and Chief Executive Officer, International Commercial Insurance and Global Personal Insurance Don Bailey - Executive Vice President and Chief Executive Officer, North America Insurance Conference Call Participants Alex Scott - Barclays Meyer Shields - KBW Jon Newsome - Piper Sandler Michael Zaremski - BMO Capital Markets Operator Good day and welcome to …

Interest in artificial intelligence (AI) has reportedly led to a turnaround for China's Alibaba. As Bloomberg News reported Wednesday (Feb. 12), the eCommerce conglomerate had virtually slunk into obscurity after a long regulatory crackdown in China.

Continued strength in RPT is likely to have boosted DaVita's top line in the fourth quarter despite supply challenges weighing on its performance.

AVO leverages its global sourcing network to meet demand and optimize margins, strengthening its performance. We evaluate if the stock is a buy at the current levels.

VIAV launches the industry's first Edge Grandmaster Clock for PNT resilience.

GPN's fourth-quarter earnings are likely to have benefited from growing revenues from Americas and Europe operations.

Tesla's recent price drop, triggered by Elon Musk's bid for OpenAI, presents a potential buying opportunity. While concerns about Musk's focus and the OpenAI situation exist, they appear overblown.

Rigetti benefits from an expanding clientele and a strong foothold in the quantum computing space despite quantum market challenges.

CG's fourth-quarter 2024 results benefit from growth in segment fee revenues. Yet, an increase in expenses acts as a headwind.

When thinking of Consumer Staples titans, Coca-Cola KO and PepsiCo PEP undoubtedly jump to the forefront of many minds. Both have established themselves over decades of successful operations, also rewarding shareholders nicely along the way.

The headline numbers for Denny's (DENN) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

While the top- and bottom-line numbers for Sonic Automotive (SAH) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Denny's Corporation remains a “don't buy” due to ongoing fundamental issues, including competition, high egg prices, and labor costs impacting earnings. Q4 revenues fell 0.6% year-over-year, missing expectations by $1.3 million, with slight improvements in franchise margins but pressured company-owned store margins. The company has significant debt, with $271.9 million outstanding and high-interest expenses, despite some DENN stock repurchases and CAPEX investments.

NEW YORK, NY / ACCESS Newswire / February 12, 2025 / If you suffered a loss on your Nextracker Inc. (NASDAQ:NXT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/nextracker-inc-lawsuit-submission-form?prid=129035&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 12, 2025 / If you suffered a loss on your FTAI Aviation Ltd. (NASDAQ:FTAI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/ftai-aviation-ltd-lawsuit-submission-form?prid=129040&wire=1 or contact Joseph E.

NEW YORK, NY / ACCESS Newswire / February 12, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of e.l.f. Beauty, Inc. ("e.l.f.

NEW YORK, NY / ACCESS Newswire / February 12, 2025 / If you suffered a loss on your AstraZeneca PLC (NASDAQ:AZN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/astrazeneca-plc-lawsuit-submission-form?prid=129038&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 12, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of CARGO Therapeutics, Inc. ("CARGO Therapeutics, Inc.") (NASDAQ:CRGX) concerning possible violations of federal securities laws. On January 29, 2025, CARGO announced in a press release that it "has elected to discontinue FIRCE-1, a Phase 2 clinical study of firi-cel for patients with large B-cell lymphoma (LBCL) whose disease relapsed or was refractory (R/R) to CD19 CAR T-cell therapy.

NEW YORK, NY / ACCESS Newswire / February 12, 2025 / If you suffered a loss on your MGP Ingredients, Inc. (NASDAQ:MGPI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/mgp-ingredients-inc-lawsuit-submission-form?prid=129032&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 12, 2025 / If you suffered a loss on your Innovative Industrial Properties, Inc. (NYSE:IIPR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/innovative-industrial-properties-inc-lawsuit-submission-form?prid=129029&wire=1 or contact Joseph E. Levi, Esq.